Showing results (1281-1290 of 1,341) with videos related to
Sort By:
Pageof 135
Open Forum Infectious Diseases|September 24, 2021
A Baker's Dozen of Top Antimicrobial Stewardship Intervention Publications in 2020Sarah B Green, Kayla R Stover, Katie Barber, et al.Cancer Treatment Reports|February 1, 1983
Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant gliomaS B Green, D P Byar, M D Walker, et al.Human Gene Therapy. Clinical Development|October 4, 2018
Toxicology and Pharmacology of an AAV Vector Expressing Codon-Optimized RPGR in RPGR-Deficient Rd9 MiceChunjuan Song, Thomas J Conlon, Wen-Tao Deng, et al.Diabetes Care|October 30, 2021
Cluster Analysis of Cardiovascular Phenotypes in Patients With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease: A Potential Approach to Precision MedicineAbhinav Sharma, Yinggan Zheng, Justin A Ezekowitz, et al.Diabetes Care|June 23, 2012
Intensive glycemic control is not associated with fractures or falls in the ACCORD randomized trialAnn V Schwartz, Karen L Margolis, Deborah E Sellmeyer, et al.The Lancet. Diabetes & Endocrinology|October 13, 2025
Effects of empagliflozin on conventional and exploratory acute and chronic kidney outcomes: an individual participant-level meta-analysisWilliam G Herrington, Zhaojing J Che, Rebecca Sardell, et al.Eclinicalmedicine|July 21, 2025
Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trialJunwen Zhou, Claire Williams, Natalie Staplin, et al.Connected Health|March 2, 2022
The worldwide impact of telemedicine during COVID-19: current evidence and recommendations for the futureStefano Omboni, Raj S Padwal, Tourkiah Alessa, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 12, 2024
The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trialParminder K Judge, Katherine R Tuttle, Natalie Staplin, et al.JCI Insight|August 8, 2023
Mitochondrial metabolites predict adverse cardiovascular events in individuals with diabetesJessica A Regan, Robert J Mentz, Maggie Nguyen, et al.Pageof 135